“The Supreme Court appeared unlikely to reimpose special restrictions on the abortion pill mifepristone, after arguments Tuesday where justices suggested that rolling back access to the drug was too extraordinary a remedy simply to protect doctors who oppose abortion from the risk of having to treat a patient suffering complications in an emergency room,” the Wall Street Journal reports.
“The case is the first major abortion issue to reach the Supreme Court after it overruled Roe v. Wade two years ago, rescinding women’s constitutional right to end unwanted pregnancies before fetal viability the justices had recognized in 1973.”
“While the 2022 decision made abortion regulation largely a matter of state law, Tuesday’s case has the potential to restrict access to medication abortion, the most common form of the procedure, even in states which protect reproductive rights.”
